ACB
Aurora Cannabis Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.95
+1.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 49.83x
- P/E 2028E
- 22.97x
- P/S forward
- 1.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.65x
- Price / sales
- 1.19x
- Price / cash flow
- -12.28x
Enterprise value
- Enterprise value
- $158.4M
- EV / sales
- 0.75x
- EV / EBITDA
- -3.26x
- EV / EBIT
- -2.54x
- Market cap
- $250.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026